{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T21:50:38Z","timestamp":1773525038508,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10549-026-07914-8","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:00:54Z","timestamp":1771484454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of regional nodal irradiation in clinically node-positive breast cancer patients who undergo neoadjuvant chemotherapy and breast-conserving surgery"],"prefix":"10.1007","volume":"216","author":[{"given":"Mahtab","family":"Vasigh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin D.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill S.","family":"Hasler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Aggon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly B.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penny R.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea S.","family":"Porpiglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary T.","family":"Pronovost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Pierotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Cruz Pico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Bleicher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"4","key":"7914_CR1","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","volume":"260","author":"JC Boughey","year":"2014","unstructured":"Boughey JC, McCall LM, Ballman KV, Mittendorf EA, Ahrendt GM, Wilke LG et al (2014) Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (alliance) prospective multicenter clinical trial. Ann Surg 260(4):608","journal-title":"Ann Surg"},{"issue":"7","key":"7914_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G et al (2013) Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol 14(7):609\u2013618","journal-title":"Lancet Oncol"},{"key":"7914_CR3","unstructured":"Network NCC. National comprehensive cancer network breast cancer. NCCN Clinical practice guidelines in oncology version.1"},{"issue":"4","key":"7914_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1415369","volume":"373","author":"PM Poortmans","year":"2015","unstructured":"Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H et al (2015) Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 373(4):317\u2013327","journal-title":"N Engl J Med"},{"issue":"4","key":"7914_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJMoa1415340","volume":"373","author":"TJ Whelan","year":"2015","unstructured":"Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A et al (2015) Regional nodal irradiation in early-stage breast cancer. N Engl J Med 373(4):307\u2013316","journal-title":"N Engl J Med"},{"issue":"1","key":"7914_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.clbc.2018.08.009","volume":"19","author":"WK Cho","year":"2019","unstructured":"Cho WK, Park W, Choi DH, Kim YB, Kim JH, Kim SS et al (2019) Role of elective nodal irradiation in patients with ypn0 after neoadjuvant chemotherapy followed by breast-conserving surgery (KROG 16-16). Clin Breast Cancer 19(1):78\u201386","journal-title":"Clin Breast Cancer"},{"key":"7914_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1200\/EDBK_237701","volume":"39","author":"S Carter","year":"2019","unstructured":"Carter S, Neuman H, Mamounas EP, Bedrosian I, Moulder S, Montero AJ et al (2019) Debating the optimal approach to nodal management after pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer. Am Soc Clin Oncol Educ Book 39:42\u201348","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"32","key":"7914_CR8","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1200\/JCO.2011.40.8369","volume":"30","author":"EP Mamounas","year":"2012","unstructured":"Mamounas EP, Anderson SJ, Dignam JJ, Bear HD, Julian TB, Geyer CE Jr et al (2012) Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. J Clin Oncol 30(32):3960\u20133966","journal-title":"J Clin Oncol"},{"issue":"12","key":"7914_CR9","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","volume":"3","author":"DJ Boffa","year":"2017","unstructured":"Boffa DJ, Rosen JE, Mallin K, Loomis A, Gay G, Palis B et al (2017) Using the National Cancer Database for outcomes research: a review. JAMA Oncol 3(12):1722\u20131728","journal-title":"JAMA Oncol"},{"key":"7914_CR10","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1245\/s10434-019-07213-1","volume":"26","author":"K Mallin","year":"2019","unstructured":"Mallin K, Browner A, Palis B, Gay G, McCabe R, Nogueira L et al (2019) Incident cases captured in the National Cancer Database compared with those in US population based central cancer registries in 2012\u20132014. Ann Surg Oncol 26:1604\u20131612","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"7914_CR11","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","volume":"15","author":"B Fisher","year":"1997","unstructured":"Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG et al (1997) Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15(7):2483\u20132493","journal-title":"J Clin Oncol"},{"issue":"5","key":"7914_CR12","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1200\/JCO.2007.15.0235","volume":"26","author":"P Rastogi","year":"2008","unstructured":"Rastogi P, Anderson SJ, Bear HD, Geyer CE, Kahlenberg MS, Robidoux A et al (2008) Preoperative chemotherapy: updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27. J Clin Oncol 26(5):778\u2013785","journal-title":"J Clin Oncol"},{"key":"7914_CR13","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1245\/s10434-018-6531-5","volume":"25","author":"BL Murphy","year":"2018","unstructured":"Murphy BL, Day CN, Hoskin TL, Habermann EB, Boughey JC (2018) Neoadjuvant chemotherapy use in breast cancer is greatest in excellent responders: triple-negative and HER2+ subtypes. Ann Surg Oncol 25:2241\u20132248","journal-title":"Ann Surg Oncol"},{"issue":"22","key":"7914_CR14","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","volume":"376","author":"N Masuda","year":"2017","unstructured":"Masuda N, Lee S-J, Ohtani S, Im Y-H, Lee E-S, Yokota I et al (2017) Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med 376(22):2147\u20132159","journal-title":"N Engl J Med"},{"issue":"7","key":"7914_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa1814017","volume":"380","author":"G Von Minckwitz","year":"2019","unstructured":"Von Minckwitz G, Huang C-S, Mano MS, Loibl S, Mamounas EP, Untch M et al (2019) Trastuzumab emtansine for residual invasive HER2-positive breast cancer. N Engl J Med 380(7):617\u2013628","journal-title":"N Engl J Med"},{"issue":"4","key":"7914_CR16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1001\/jamaoncol.2016.4163","volume":"3","author":"M Pilewskie","year":"2017","unstructured":"Pilewskie M, Morrow M (2017) Axillary nodal management following neoadjuvant chemotherapy: a review. JAMA Oncol 3(4):549\u2013555","journal-title":"JAMA Oncol"},{"key":"7914_CR17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.6004\/jnccn.2020.0016","volume":"18","author":"J William","year":"2020","unstructured":"William J, Gradishar W, Aft R, Agnese D, Allison K, Blair S (2020) NCCN guidelines: breast cancer, version 6. J Natl Compr Canc Netw 18:452\u2013478","journal-title":"J Natl Compr Canc Netw"},{"key":"7914_CR18","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1245\/s10434-019-07785-y","volume":"26","author":"A Weiss","year":"2019","unstructured":"Weiss A, Wong S, Golshan M, Freedman RA, Metzger O, Bellon J et al (2019) Patterns of axillary management in stages 2 and 3 hormone receptor-positive breast cancer by initial treatment approach. Ann Surg Oncol 26:4326\u20134336","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"7914_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.6004\/jnccn.2020.0016","volume":"18","author":"WJ Gradishar","year":"2020","unstructured":"Gradishar WJ, Anderson BO, Abraham J, Aft R, Agnese D, Allison KH et al (2020) Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 18(4):452\u2013478","journal-title":"J Natl Compr Canc Netw"},{"key":"7914_CR20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.e12524","author":"E Garcia Torralba","year":"2020","unstructured":"Garcia Torralba E, de la Morena P, Garcia Gomez M, Ivars Rubio A, Garcia Martinez E, Garcia-Garre E et al (2020) High-risk of recurrence for nodal micrometastasis with breast pathologic complete response (ypT0\/Tis ypN1mi) after neoadjuvant chemotherapy. Am Soc Clinic Oncol. https:\/\/doi.org\/10.1200\/JCO.2020.38.15_suppl.e12524","journal-title":"Am Soc Clinic Oncol"},{"issue":"12","key":"7914_CR21","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","volume":"21","author":"PM Poortmans","year":"2020","unstructured":"Poortmans PM, Weltens C, Fortpied C, Kirkove C, Peignaux-Casasnovas K, Budach V et al (2020) Internal mammary and medial supraclavicular lymph node chain irradiation in stage I\u2013III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial. Lancet Oncol 21(12):1602\u20131610","journal-title":"Lancet Oncol"},{"key":"7914_CR22","unstructured":"Regional NFIARPICTEP-MCa, Neoadjuvant NXaP-LRNXiPWPANB, Available CWCtPNANaNC, https:\/\/www.clinicaltrials.gov\/study\/NCT01872975?cond=Phase%20III%20Clinical%20Trial%20Evaluating%20Post-o,Mastectomy%20Chestwall%20and%20Regional%20Nodal%20XRT%20&rank=1"},{"issue":"1-2","key":"7914_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.canrad.2021.11.013","volume":"26","author":"C Hennequin","year":"2022","unstructured":"Hennequin C, Belkac\u00e9mi Y, Bourgier C, Cowen D, Cutuli B, Fourquet A et al (2022) Radiotherapy of breast cancer. Cancer Radiother 26(1\u20132):221\u2013230","journal-title":"Cancer Radiother"},{"key":"7914_CR24","unstructured":"https:\/\/www.nccn.org\/education-research\/educational-events-and-programs\/nccn-2024-breast-cancer-congress."},{"key":"7914_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1151460","volume":"13","author":"T Elumalai","year":"2023","unstructured":"Elumalai T, Jain U, Coles CE, Benson JR (2023) The role of irradiation in the management of the axilla in early breast cancer patients. Front Oncol 13:1151460. https:\/\/doi.org\/10.3389\/fonc.2023.1151460","journal-title":"Front Oncol"},{"issue":"9","key":"7914_CR26","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.clon.2019.05.021","volume":"31","author":"A Gandhi","year":"2019","unstructured":"Gandhi A, Coles C, Makris A, Provenzano E, Goyal A, Maxwell A et al (2019) Axillary surgery following neoadjuvant chemotherapy\u2013multidisciplinary guidance from the association of breast surgery, faculty of clinical oncology of the royal college of radiologists, UK breast cancer group, national coordinating committee for breast pathology and British society of breast radiology. Clin Oncol (R Coll Radiol) 31(9):664\u2013668","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"7914_CR27","unstructured":"Network NCC. NCCN clinical practice guidelines in oncology: breast cancer, version 2. Fort Washington: National Comprehensive Cancer Network. 2014."},{"issue":"1","key":"7914_CR28","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S1470-2045(20)30580-5","volume":"22","author":"P Dubsky","year":"2021","unstructured":"Dubsky P, Pinker K, Cardoso F, Montagna G, Ritter M, Denkert C et al (2021) Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox. Lancet Oncol 22(1):e18\u2013e28","journal-title":"Lancet Oncol"},{"issue":"4_Supplement","key":"7914_CR29","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS18-OT2-04-01","volume":"79","author":"E Mamounas","year":"2019","unstructured":"Mamounas E, Bandos H, White J, Julian T, Khan A, Shaitelman S et al (2019) Abstract OT2-04-01: phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to whole breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with pathologically positive axillary (PPAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC): NRG Oncology\/NSABP b-51\/RTOG 1304. Cancer Res 79(4_Supplement):OT2-04-1-OT2--1","journal-title":"Cancer Res"},{"issue":"13","key":"7914_CR30","doi-asserted-by":"publisher","first-page":"8813","DOI":"10.1245\/s10434-024-16143-6","volume":"31","author":"JN Limberg","year":"2024","unstructured":"Limberg JN, Jones T, Thomas SM, Ntowe KW, Dalton JC, van den Bruele AB et al (2024) Omission of axillary lymph node dissection in patients with residual nodal disease after neoadjuvant chemotherapy. Ann Surg Oncol 31(13):8813\u20138820","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"7914_CR31","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ijrobp.2022.03.007","volume":"113","author":"RBM Vega","year":"2022","unstructured":"Vega RBM, Wang S, Brooks ED, Oladeru OT, Lockney NA, Spiguel LE et al (2022) Evaluating regional nodal irradiation allocation and association with oncologic outcomes in NSABP B-18, B-27, B-40, and B-41. Int J Radiat Oncol Biol Phys 113(3):542\u2013551","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"22","key":"7914_CR32","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1200\/JCO.2003.12.005","volume":"21","author":"HD Bear","year":"2003","unstructured":"Bear HD, Anderson S, Brown A, Smith R, Mamounas EP, Fisher B et al (2003) The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 21(22):4165\u20134174","journal-title":"J Clin Oncol"},{"issue":"12","key":"7914_CR33","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","volume":"23","author":"EP Mamounas","year":"2005","unstructured":"Mamounas EP, Brown A, Anderson S, Smith R, Julian T, Miller B et al (2005) Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23(12):2694\u20132702","journal-title":"J Clin Oncol"},{"issue":"2","key":"7914_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.clbc.2021.06.003","volume":"22","author":"A Schlafstein","year":"2022","unstructured":"Schlafstein A, Liu Y, Goyal S, Kahn S, Godette K, Lin J et al (2022) Regional nodal irradiation for clinically node-positive breast cancer patients with pathologic negative nodes after neoadjuvant chemotherapy. Clin Breast Cancer 22(2):127\u2013135","journal-title":"Clin Breast Cancer"},{"issue":"9_Supplement","key":"7914_CR35","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS23-GS02-07","volume":"84","author":"E Mamounas","year":"2024","unstructured":"Mamounas E, Bandos H, White J, Julian T, Khan A, Shaitelman S et al (2024) Abstract GS02-07: loco-regional irradiation in patients with biopsy-proven axillary node involvement at presentation who become pathologically node-negative after neoadjuvant chemotherapy: primary outcomes of NRG oncology\/NSABP B-51\/RTOG 1304. Cancer Res 84(9_Supplement):GS02-7-GS-7","journal-title":"Cancer Res"},{"issue":"11","key":"7914_CR36","doi-asserted-by":"publisher","first-page":"7445","DOI":"10.1245\/s10434-024-15704-z","volume":"31","author":"CL Cardarelli","year":"2024","unstructured":"Cardarelli CL, Dalton EC, Chang C, Williams AD, Aggon AA, Porpiglia AS et al (2024) Should palpable nodes be exclusionary in patients who are otherwise candidates for ACOSOG Z0011-type trials? Ann Surg Oncol 31(11):7445\u20137458","journal-title":"Ann Surg Oncol"},{"issue":"9_Supplement","key":"7914_CR37","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS23-PS04-03","volume":"84","author":"M Vasigh","year":"2024","unstructured":"Vasigh M, Bleicher R, Williams A, Aggon A, Pronovost M, Porpiglia A et al (2024) Abstract PS04-03: survival benefit of regional nodal irradiation in clinically node-positive breast cancer following neoadjuvant chemotherapy and breast-conserving surgery. Cancer Res 84(9_Supplement):PS04-3-PS-3","journal-title":"Cancer Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07914-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-07914-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07914-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T21:01:28Z","timestamp":1773522088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-026-07914-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["7914"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-07914-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Fox Chase Cancer Center, Philadelphia, PA: 23\u20139902, 1\/30\/2023.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No consent was required for deidentified information.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participant"}},{"value":"No consent was required for deidentified information.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"14"}}